Search results
Results from the WOW.Com Content Network
Cancer treatment centres in Singapore are generally located in both public and private hospitals. These units and medical centres specialise in the treatment of cancer . [1] Raffles Hospital; Parkway East Hospital - Parkway Cancer Centre; Gleneagles Hospital - Parkway Cancer Centre [2] Tan Tock Seng Hospital; Singapore General Hospital
Non-small cell lung cancer, oesophageal cancer, uterine cervical cancer, head and neck cancer and urothelial cancer: Nephrotoxicity, myelosuppression and nausea and vomiting (30-90%). Oxaliplatin: IV: Reacts with DNA, inducing apoptosis, non-cell cycle specific. Colorectal cancer, oesophageal cancer and gastric cancer
This is a list of chemotherapeutic agents, also known as cytotoxic agents or cytostatic drugs, that are known to be of use in chemotherapy for cancer.This list is organized by type of agent, although the subsections are not necessarily definitive and are subject to revision.
This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.
The National University Cancer Institute, Singapore (NCIS) is a national specialty centre and the only public cancer centre in Singapore treating both paediatric and adult cancers in one facility. The NCIS offers a broad spectrum of cancer care and management that ranges from public education, screening and early diagnosis, to treatment, and ...
(Reuters) -AstraZeneca plans to build a $1.5 billion manufacturing facility in Singapore to produce a promising category of cancer-killing drugs called antibody-drug conjugates (ADCs), the Anglo ...
This drug targets a number of cancers, including colorectal, ovarian and pancreatic cancers, which contribute to a significant proportion of Singapore's cancer burden. [16] A*STAR further announced that its second locally developed cancer drug, ETC-206, which targets blood cancers, has advanced to first-in-man trials in 2016. [17]
The healthcare system in Singapore is divided into two sectors; statutory boards and institutions (which are then divided into public and private streams). [10] There are a variety of statutory boards in place, including the Medical Council, Dental Council, Nursing Board, Pharmacy Council, and Optometrists and Opticians Board. [10]